Service for immunomax TM monoclonal antibody
Ended Purchase Order Awarded Last action
- Contract number
- W81XWH17P0053
- Awardee
-
Abpro Corporation UEI P2U7GC7JGMC3
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $12,445
Award facts
- Opportunity
-
- W81XWH16T0200 Solicitation number
- Development of Monoclonal Antibodies Against Malaria Parasite Award Notice · Posted Sep 28, 2017
- Contract value 100% obligated
- $12,445.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Woburn, MA 01801, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$420 | |
| Exercise an Option | $615 | |
| Other Administrative Action | $0 | |
| Original award | $12,250 |
Quick answers
Who was awarded contract W81XWH17P0053?
W81XWH17P0053 was awarded to Abpro Corporation by Medical Command (Department of the Army) on January 27, 2017.
How much is contract W81XWH17P0053 worth?
The government has obligated $12,445 on W81XWH17P0053.
Was contract W81XWH17P0053 competed?
The extent of competition for W81XWH17P0053 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award